NCL  
Nanotechnology Characterization Laboratory Skip Navigation
MEASURING - Next generation technologies for cancer
         
 NCL Spotlight
   

Nanotechnology Characterization Lab

 
 News & Events
   NCL is currently
accepting applications
for characterization.
The next submission
deadline is
June 2, 2014.
View submission procedures and evaluation criteria for NCL review of nano-materials in the NCL’s Quick Guide to the Application Process.
 
   Assay Cascade
Protocols
 
   NCL Video Protocol
Series
Dynamic Light Scattering

   Working with the NCL
Quick guide to who the NCL is and what we can do for you.”

Visit the nano.cancer.gov website!
 

Eliminating suffering and death from cancer requires an unprecedented collaborative effort that leverages resources from government, industry, and academia. Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nanotechnology Characterization Laboratory to perform preclinical efficacy and toxicity testing of nanoparticles.

The NCL serves as a national resource and knowledge base for all cancer researchers to facilitate the regulatory review of nanotechnologies intended for cancer therapies and diagnostics. By providing the critical infrastructure and characterization services to nanomaterial providers, the NCL accelerates the transition of basic nanoscale particles and devices into clinical applications, thereby reducing suffering and death from cancer.

As part of its assay cascade, the NCL characterizes nanoparticles' physical attributes, their in vitro biological properties, and their in vivo compatibility using animal models. The time required to characterize nanomaterials from receipt through the in vivo phase is approximately one year.

   Learn about the application process to submit materials.

 

 

The Promise of Nanotechnology

View video
 
 Meet Us

5th FIP Pharmaceutical Sciences World Congress 2014
Melbourne, Australia; April 13-16, 2014

The Tenth International Nanotechnology Conference on Communication and Cooperation (INC 10)
Gaithersburg, MD; May 13-15, 2014

Biodendrimer 2014
Lugano, Switzerland; June 18-20 2014

CLINAM
Basel, Switzerland; June 22-25, 2014

 

Mewsletter Email Signup
Subscribe to NCL News
 
 
         
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.govNCI - Alliance for Nanotechnology in Cancer
National Cancer Institute U.S. National Institutes of Health www.cancer.gov Nanotechnology Characterization Lab